# A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

> **NCT04656561** · PHASE2 · COMPLETED · sponsor: **Annexon, Inc.** · enrollment: 270 (actual)

## Conditions studied

- Geographic Atrophy

## Interventions

- **DRUG:** ANX007
- **OTHER:** Sham comparator

## Key facts

- **NCT ID:** NCT04656561
- **Lead sponsor:** Annexon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-09-13
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04656561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04656561, "A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04656561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*